Business Wire – RegeneRx Awarded Australian Patent for New TB4 Applications
July 8, 2010 — HASH(0x2a966b4c10) ROCKVILLE, Md. — RegeneRx Biopharmaceuticals, Inc. (NYSE Amex: RGN) (the âÂ?Â?CompanyâÂ? or…
More: continued here
Filed under Acne Treatments by on Jul 10th, 2010.
Leave a Comment